Francesca M. Buffa

14.2k total citations · 4 hit papers
177 papers, 9.3k citations indexed

About

Francesca M. Buffa is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Francesca M. Buffa has authored 177 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Molecular Biology, 86 papers in Cancer Research and 36 papers in Oncology. Recurrent topics in Francesca M. Buffa's work include Cancer, Hypoxia, and Metabolism (50 papers), RNA modifications and cancer (30 papers) and Cancer-related molecular mechanisms research (29 papers). Francesca M. Buffa is often cited by papers focused on Cancer, Hypoxia, and Metabolism (50 papers), RNA modifications and cancer (30 papers) and Cancer-related molecular mechanisms research (29 papers). Francesca M. Buffa collaborates with scholars based in United Kingdom, United States and Italy. Francesca M. Buffa's co-authors include Adrian L. Harris, Jiannis Ragoussis, Catharine West, Helen Sheldon, Crispin Miller, Carme Camps, Elena Favaro, Harriet E. Gee, Laura Winchester and Adrian M. Jubb and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Francesca M. Buffa

170 papers receiving 9.2k citations

Hit Papers

hsa-miR-210 Is Induced by Hypoxia and Is an Independent P... 2008 2026 2014 2020 2008 2014 2011 2014 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca M. Buffa United Kingdom 46 6.1k 5.1k 1.8k 1.1k 679 177 9.3k
Rob A. Cairns Canada 24 6.1k 1.0× 5.4k 1.1× 1.5k 0.8× 697 0.6× 430 0.6× 34 9.9k
Patrick S. Ward United States 20 8.4k 1.4× 6.6k 1.3× 1.4k 0.7× 963 0.9× 314 0.5× 26 12.4k
Kounosuke Watabe United States 56 6.8k 1.1× 4.3k 0.9× 2.5k 1.4× 1.6k 1.5× 552 0.8× 166 10.0k
Fan Fan United States 53 6.3k 1.0× 3.4k 0.7× 3.6k 2.0× 1.1k 1.0× 491 0.7× 150 10.1k
Efthimios Sivridis Greece 55 5.2k 0.9× 4.3k 0.9× 2.6k 1.4× 1.4k 1.3× 586 0.9× 245 10.2k
Alberto Villanueva Spain 49 6.6k 1.1× 3.9k 0.8× 2.4k 1.3× 1.2k 1.1× 468 0.7× 138 9.9k
Valeria R. Fantin United States 32 6.9k 1.1× 4.8k 0.9× 1.5k 0.8× 882 0.8× 250 0.4× 55 11.0k
Feng Jiang United States 50 5.7k 0.9× 3.9k 0.8× 1.8k 1.0× 1.2k 1.1× 284 0.4× 134 8.4k
Yulei Wang United States 34 7.7k 1.3× 5.5k 1.1× 1.9k 1.0× 853 0.8× 245 0.4× 82 10.6k
Ja Seung Koo South Korea 43 2.7k 0.4× 2.8k 0.6× 2.4k 1.3× 807 0.7× 460 0.7× 231 6.3k

Countries citing papers authored by Francesca M. Buffa

Since Specialization
Citations

This map shows the geographic impact of Francesca M. Buffa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca M. Buffa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca M. Buffa more than expected).

Fields of papers citing papers by Francesca M. Buffa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca M. Buffa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca M. Buffa. The network helps show where Francesca M. Buffa may publish in the future.

Co-authorship network of co-authors of Francesca M. Buffa

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca M. Buffa. A scholar is included among the top collaborators of Francesca M. Buffa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca M. Buffa. Francesca M. Buffa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Macaulay, Valentine M., et al.. (2025). GeneFEAST: the pivotal, gene-centric step in functional enrichment analysis interpretation. Bioinformatics. 41(3). 1 indexed citations
2.
Barberis, Alessandro, D. R. Hudson, David A. Harris, et al.. (2025). Defining hypoxia in cancer: A landmark evaluation of hypoxia gene expression signatures. Cell Genomics. 5(2). 100764–100764. 1 indexed citations
3.
Pasqualetti, Francesco, Alessandro Barberis, Nicola Montemurro, et al.. (2023). The impact of survivorship bias in glioblastoma research. Critical Reviews in Oncology/Hematology. 188. 104065–104065. 14 indexed citations
4.
Pai, Chen‐Chun, Wei‐Chen Cheng, Carol Walker, et al.. (2023). Homologous recombination suppresses transgenerational DNA end resection and chromosomal instability in fission yeast. Nucleic Acids Research. 51(7). 3205–3222. 3 indexed citations
5.
Kaeppler, Jakob, Jianzhou Chen, Mario Buono, et al.. (2022). Endothelial cell death after ionizing radiation does not impair vascular structure in mouse tumor models. EMBO Reports. 23(9). e53221–e53221. 9 indexed citations
6.
Sheldon, Helen, Esther Bridges, Ildefonso Silva, et al.. (2021). ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression. Molecular Cancer Research. 19(11). 1957–1969. 7 indexed citations
7.
Dhawan, Andrew, Alessandro Barberis, Enric Domingo, et al.. (2019). Guidelines for using sigQC for systematic evaluation of gene signatures. Nature Protocols. 14(5). 1377–1400. 20 indexed citations
8.
Burdová, Kamila, Hongbin Yang, Samuel Hume, et al.. (2019). E2F1 proteolysis via SCF ‐cyclin F underlies synthetic lethality between cyclin F loss and Chk1 inhibition. The EMBO Journal. 38(20). e101443–e101443. 42 indexed citations
9.
Morotti, Matteo, Esther Bridges, Alessandro Valli, et al.. (2019). Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer. Proceedings of the National Academy of Sciences. 116(25). 12452–12461. 105 indexed citations
10.
Pajic, Marina, Danielle Froio, Sheridan Daly, et al.. (2017). miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS Defense. Cancer Research. 78(2). 501–515. 110 indexed citations
11.
D’Costa, Zenobia, Keaton Jones, Abul Kalam Azad, et al.. (2017). Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer. Cancer Research. 77(21). 5952–5962. 51 indexed citations
12.
Yang, Lingjian, Janet Taylor, Amanda Eustace, et al.. (2017). A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients. Clinical Cancer Research. 23(16). 4761–4768. 89 indexed citations
13.
Serres, Sébastien, Paola Infante, Alessandro Barberis, et al.. (2016). SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development. The EMBO Journal. 35(13). 1400–1416. 50 indexed citations
14.
Roxanis, Ioannis, Helen Sheldon, Francesca M. Buffa, et al.. (2015). Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer. Oncotarget. 6(8). 5678–5694. 31 indexed citations
15.
Kumar, Krishan, Simon Wigfield, Harriet E. Gee, et al.. (2013). Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts. Journal of Molecular Medicine. 91(6). 749–758. 63 indexed citations
16.
Eustace, Amanda, Navin Mani, Paul N. Span, et al.. (2013). A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer. Clinical Cancer Research. 19(17). 4879–4888. 167 indexed citations
17.
Ghazoui, Zara, Francesca M. Buffa, Anita K. Dunbier, et al.. (2011). Close and Stable Relationship between Proliferation and a Hypoxia Metagene in Aromatase Inhibitor–Treated ER-Positive Breast Cancer. Clinical Cancer Research. 17(9). 3005–3012. 26 indexed citations
18.
Buffa, Francesca M., Carlos Camps, Laura Winchester, et al.. (2011). microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer. Cancer Research. 71(17). 5635–5645. 251 indexed citations
19.
Winter, Stuart C., Francesca M. Buffa, Craig Miller, et al.. (2009). Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers (vol 67, pg 3441, 2007). Cancer Research. 69. 1695–1695.
20.
Winter, Stuart C., Francesca M. Buffa, Priyamal Silva, et al.. (2007). Relation of a Hypoxia Metagene Derived from Head and Neck Cancer to Prognosis of Multiple Cancers. Cancer Research. 67(7). 3441–3449. 275 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026